Research Article
A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway
Figure 3
(a) Mass spectroscopy of the ruthenium-fluvastatin complex. (b) Possible fragmentation mechanism of the ruthenium-fluvastatin molecule.
(a) |
(b) |